Literature DB >> 29588192

Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns.

Luis E Pavillard1, Fabiola Marín-Aguilar1, Pedro Bullon1, Mario D Cordero2.   

Abstract

Cardiovascular diseases (CVD) are the leading cause of death worldwide, with high prevalence in industrialized countries. Cardiovascular risk factors are mainly influenced by diet, which like other lifestyle factors can be modified to either reduce or increase cardiovascular risk. Other metabolic diseases such as metabolic syndrome, type II diabetes mellitus, and obesity are associated to CVD and highly influenced by the diet. Inflammation has demonstrated to be a key factor in the biological progress of these diseases. Interestingly, IL-1β which is associated to several steps in the development of atherosclerosis, heart disease, and the association of obesity and type II diabetes with CVD, is activated by the inflammasome complex, a multiprotein complex composed of an intracellular sensor, typically a Nod-like receptor (NLR), the precursor procaspase-1, and the adaptor ASC (apoptosis-associated speck-like protein containing a CARD. In the last years, inflammasome complex has been studied in depth and has been associated with the effect of unhealthy diets both from a clinical and experimental view point. We have reviewed the evidences supporting the role of the inflammasome complex in the development of cardiovascular pathology by unhealthy diets and the therapeutic perspectives.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular diseases; NLRP3-inflammasome; Unhealthy diets

Mesh:

Substances:

Year:  2018        PMID: 29588192     DOI: 10.1016/j.phrs.2018.03.018

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  20 in total

1.  NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression.

Authors:  Fangfang Li; Hao Zhang; Lu Yang; Hui Yong; Qingqing Qin; Mengtong Tan; Luhong Xu; Kai Liang; Jing Zong; Wenhao Qian
Journal:  J Mol Med (Berl)       Date:  2018-08-29       Impact factor: 4.599

2.  Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.

Authors:  Anke C Fender; Sonja Kleeschulte; Svenja Stolte; Katja Leineweber; Markus Kamler; Johannes Bode; Na Li; Dobromir Dobrev
Journal:  Basic Res Cardiol       Date:  2020-01-07       Impact factor: 17.165

3.  The inflammasome in heart failure.

Authors:  Eleonora Mezzaroma; Antonio Abbate; Stefano Toldo
Journal:  Curr Opin Physiol       Date:  2020-10-07

4.  Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017.

Authors:  Gulbarshyn Mukasheva; Madina Abenova; Askhat Shaltynov; Oxana Tsigengage; Zhanna Mussabekova; Tolkyn Bulegenov; Gulnara Shalgumbaeva; Yuliya Semenova
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

Review 5.  Targeting the NLRP3 inflammasome in cardiovascular diseases.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Leo F Buckley; Nicola Potere; Marcello Di Nisio; Giuseppe Biondi-Zoccai; Benjamin W Van Tassell; Antonio Abbate
Journal:  Pharmacol Ther       Date:  2021-12-11       Impact factor: 13.400

6.  Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis.

Authors:  Liping Li; Chao Xing; Ji Zhou; Liangliang Niu; Bin Luo; Maomao Song; Jingping Niu; Ye Ruan; Xinghuai Sun; Yuan Lei
Journal:  Part Fibre Toxicol       Date:  2021-03-04       Impact factor: 9.400

Review 7.  Emerging Roles of Inflammasomes in Cardiovascular Diseases.

Authors:  Yingnan Liao; Kui Liu; Liyuan Zhu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

Review 8.  Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease.

Authors:  Andrea Baragetti; Alberico Luigi Catapano; Paolo Magni
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

Review 9.  From Mitochondria to Atherosclerosis: The Inflammation Path.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; José A Sánchez-Alcázar
Journal:  Biomedicines       Date:  2021-03-05

Review 10.  Nutraceutical Compounds Targeting Inflammasomes in Human Diseases.

Authors:  Beatriz Castejón-Vega; Francesca Giampieri; José M Alvarez-Suarez
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.